BiologicsTherapeuticsVerséa™ Biologics at the North American Neuromodulation Society 26th Annual Meeting

January 16, 2023by Natasha Svast

Members of our Verséa Biologics team (Sunil Panchal, MD, Chief Scientific Officer, Verséa Biologics; David Kloth, M.D., Medical Director, Verséa Biologics; and Bill Bigham, VP of Sales, Verséa Biologics) attended this year’s North American Neuromodulation Society 26th Annual Meeting. At the event they had a chance to present our innovative portfolio of Biologics products which provide natural regenerative effects for various indications in the areas of spine surgery, orthopedics, trauma, podiatry, interventional pain and other indications requiring bone and tissue regeneration.

If you want to learn more about the products, let us know at biologics@versea.com or fill out our online Connect With Us form.

 

 

………….

About Verséa™ Biologics
Verséa™ Biologics, LLC, a business division of Verséa Health, Inc. (“Verséa”), one of the fastest growing U.S. healthcare companies.

Verséa Biologics is focused on using the latest scientific and clinical advancements in regenerative medicine to provide safe and effective treatment solutions for patients. 

Led by Jimmy DeMesa, MD, MBA and Sunil Panchal, MD, PhD, Verséa Biologics is building an innovative portfolio of products which provide natural regenerative effects for various indications in the areas of spine surgery, orthopedics, trauma, podiatry, interventional pain and other indications requiring bone and tissue regeneration.